InMed Pharmaceuticals (OTCMKTS:IMLFF – Free Report) is one of 365 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its peers? We will compare InMed Pharmaceuticals to related businesses based on the strength of its dividends, institutional ownership, valuation, profitability, risk, earnings and analyst recommendations. Insider & Institutional Ownership 23.2% of shares […]